💰 Total Deal Value: ₹25,689 Cr 🏢 Seller: KKR (Private Equity Firm) 📈 Stake Acquired: 46.39% + 26% via open offer 📅 Timeline: 15–18 months to complete
🔹 Torrent rises to Top 5 Pharma Cos in India 🔹 Gains chronic brands: Nicardia, Rantac 🔹 Expands into ophthalmology, IVF, CDMO
📊 EPS accretive by FY28 📉 Net debt-free by FY29 ⚖️ Cost & revenue synergies expected in FY27–28
✅ KKR exits with 5x return 📈 36% IRR since 2020 💼 One of the most profitable PE exits in Indian pharma!
📈 Torrent shares rose 4% 📉 JB Chemicals stock down 7% 📣 Analysts call it a “Bold, Long-Term Move”